Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in Hospitals

Antimicrobial resistance results in increased morbidity, mortality, and costs of health care. Prevention of the emergence of resistance and the dissemination of resistant microorganisms will reduce these adverse effects and their attendant costs. Appropriate antimicrobial stewardship that includes o...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 1997-09, Vol.25 (3), p.584-599
Main Authors: Shlaes, David M., Gerding, Dale N., John, Joseph F., Craig, William A., Bornstein, Donald L., Duncan, Robert A., Eckman, Mark R., Farrer, William E., Greene, William H., Lorian, Victor, Levy, Stuart, McGowan, John E., Paul, Sindy M., Ruskin, Joel, Tenover, Fred C., Watanakunakorn, Chatrchai
Format: Article
Language:English
Subjects:
Anti-Bacterial Agents - therapeutic use
Antibacterial agents
Antibiotic resistance
Antibiotics
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antimicrobials
Bacteria
Bacteria - drug effects
Bacteria - genetics
Bacteria - pathogenicity
Bacterial Infections - drug therapy
Bacterial Infections - microbiology
Biological and medical sciences
Cross Infection - microbiology
Cross Infection - prevention & control
Drug Resistance, Microbial - genetics
Epidemiology
Guidelines from the Infectious Diseases Society of America
Hospital administration
Hospitalization
Hospitals
Humans
Infection control
Infections
Medical sciences
Microorganisms
Patient Isolation
Pharmacology. Drug treatments
Recommendations
Societies, Medical
United States
Virulence
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Antimicrobial resistance results in increased morbidity, mortality, and costs of health care. Prevention of the emergence of resistance and the dissemination of resistant microorganisms will reduce these adverse effects and their attendant costs. Appropriate antimicrobial stewardship that includes optimal selection, dose, and duration of treatment, as well as control of antibiotic use, will prevent or slow the emergence of resistance among microorganisms. A comprehensively applied infection control program will interdict the dissemination of resistant strains.
ISSN:1058-4838
1537-6591
DOI:10.1086/513766